Skip to content

The effect of intraoperative heating on body temperature in cesarean section women: a multicenter prospective randomized controlled clinical trial

The effect of intraoperative heating on body temperature in cesarean section women: a multicenter prospective randomized controlled clinical trial - The effect of intraoperative heating on body temperature in cesarean section women: a multicenter prospective randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090729
Enrollment
Unknown
Registered
2024-10-12
Start date
2024-10-15
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean section

Interventions

Intraoperative heating group:Heating by intraoperative heater
control group:No heating during surgery

Sponsors

Jiangxi Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: All cesarean section women aged 18-40, single pregnancy, and pregnancy period exceeding 37 weeks are eligible to participate

Exclusion criteria

Exclusion criteria: Including known bupivacaine, lidocaine allergy, known impaired thermoregulation or thyroid disease, gestational diabetes, vascular disease or skin perfusion insufficiency, ASA grade greater than Grade III, preeclampsia or eclampsia history, planned admission to intensive care unit, no eardrum/ear canal found by otoscopy, and the baseline temperature = 37 ° C

Design outcomes

Primary

MeasureTime frame
Maternal core temperature;

Secondary

MeasureTime frame
Parturient shivering;Newborn apgar score;Postpartum hypotension;Postpartum bradycardia;

Countries

China

Contacts

Public ContactLuo Heguo

Jiangxi Provincial People's Hospital

ddjy121@163.com+86 138 0703 5516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026